Reproducible and time-dependent modification of serum protein binding in Wistar Kyoto rats

Journal of Pharmacological and Toxicological Methods

Volumn 56, Issue 1, 2007, Pages 72-78

  van Steeg, Tamara J ^a   Krekels, Elke H J ^a   Danhof, Meindert ^a   de Lange, Elizabeth C M ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

1 acid glycoprotein; AGP; Free fraction, methods; Rat serum albumin; RSA; S( ) Propranolol; Serum protein binding; Unbound fraction

Indexed keywords

ALBUMIN; OROSOMUCOID; PROPRANOLOL; TURPENTINE OIL;

ALBUMIN BLOOD LEVEL; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CANNULATION; CONTROLLED STUDY; DRUG PROTEIN BINDING; EX VIVO STUDY; MALE; NONHUMAN; PROTEIN BINDING; PROTEIN BLOOD LEVEL; RAT; REPRODUCIBILITY; TIME; WISTAR KYOTO RAT;

ADRENERGIC BETA-ANTAGONISTS; ANALYSIS OF VARIANCE; ANIMALS; CATHETERIZATION; MALE; MODELS, BIOLOGICAL; OROSOMUCOID; PROPRANOLOL; PROTEIN BINDING; RATS; RATS, INBRED WKY; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN; TIME FACTORS; TURPENTINE;

RATTUS;

EID: 34249677315     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2007.02.002     Document Type: Article

References (32)

1. Arnold F.J., and Meyerson L.R. Radial immunodiffusion assay for rat alpha 1-acid glycoprotein. Pharmacology, Biochemistry and Behavior 37 (1990) 485-491
2. Belpaire, F. M., De Smet, F., Chindavijak, B., Fraeyman, N., & Bogaert, M. G., (2002). Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat. Fundamental & Clinical Pharmacology 1989;3(2):79-88. :79-88.,-88.
3. Ceciliani F., Giordano A., and Spagnolo V. The systemic reaction during inflammation: The acute-phase proteins. Protein Peptide Letters 9 (2002) 211-223
4. Chauvelot-Moachon L., Delers F., Pous C., Engler R., Tallet F., and Giroud J.P. Alpha-1-acid glycoprotein concentrations and protein binding of propranolol in Sprague-Dawley and Dark Agouti rat strains treated by phenobarbital. Journal of Pharmacology and Experimental Therapeutics 244 (1988) 1103-1108
5. Cox E.H., Kerbusch T., Van Der Graaf P.H., and Danhof M. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: Correlation with the interaction at the mu-opioid receptor. Journal of Pharmacology and Experimental Therapeutics 284 (1998) 1095-1103
6. Day, Y. S., Myszka, D.G., (2002). Characterizing a drug's primary binding site on albumin. Journal of Pharmaceutical Sciences 2003 Feb; 92(2):333-43. :333-43.,-43.
7. Derendorf H., Hochhaus G., Mollmann H., Barth J., Krieg M., Tunn S., et al. Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids. Journal of Clinical Pharmacology 33 (1993) 115-123
8. Drechou A., Perez-Gonzalez N., Biou D., Rouzeau J.D., Feger J., and Durand G. One-step purification of rat plasma alpha 1-acid glycoprotein by antibody affinity chromatography: Application to normal and inflamed rat sera. Journal of Chromatography 489 (1989) 273-281
9. Eberini I., Agnello D., Miller I., Villa P., Fratelli M., Ghezzi P., et al. Proteins of rat serum V: Adjuvant arthritis and its modulation by nonsteroidal anti-inflammatory drugs. Electrophoresis 21 (2000) 2170-2179
10. Fournier T., Medjoubi N., and Porquet D. Alpha-1-acid glycoprotein. Biochimica et Biophysica Acta 1482 (2000) 157-171
11. Frape D.L. Arterio-venous differences of NEFA during exercise. Equine Veterinary Journal 25 (1993) 4-5
12. Gabay C., and Kushner I. Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine 340 (1999) 448-454
13. Harris P., Chlouverakis C., Gloster J., and Jones J.H. Arterio-venous differences in the composition of plasma free fatty acids in various regions of the body. Clinical Science 22 (1962) 113-118
14. Jauregizar N., Calvo R., Suarez E., Quintana A., Raczka E., and Lukas J.C. Altered disposition and effect of lerisetron in rats with elevated alpha1-acid glycoprotein levels. Pharmaceutical Research 18 (2001) 838-845
15. Kessler M.A., Meinitzer A., and Wolfbeis O.S. Albumin blue 580 fluorescence assay for albumin. Analytical Biochemistry 248 (1997) 180-182
16. Kopecky Jr. V., Ettrich R., Hofbauerova K., and Baumruk V. Structure of human alpha1-acid glycoprotein and its high-affinity binding site. Biochemical and Biophysical Research Communications 300 (2003) 41-46
17. Kremer J.M., Wilting J., and Janssen L.H. Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacological Reviews 40 (1988) 1-47
18. Kushner I. The phenomenon of the acute phase response. Annals of the New York Academy of Sciences 389 (1982) 39-48
19. Mandema J.W., Sansom L.N., Dios-Vieitez M.C., Hollander-Jansen M., and Danhof M. Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity. Journal of Pharmacology and Experimental Therapeutics 257 (1991) 472-478
20. Muraikushiya M., Okada S., Kimura T., and Hasegawa R. Effects of turpentine oil pretreatment on beta-blocker pharmacokinetic parameters in rats. Journal of Pharmacy and Pharmacology 45 (1993) 836-838
21. Notarianni L.J. Plasma protein binding of drugs in pregnancy and in neonates. Clinical Pharmacokinetics 18 (1990) 20-36
22. Pardridge W.M., and Landaw E.M. Tracer kinetic model of blood-brain barrier transport of plasma protein-bound ligands. Empiric testing of the free hormone hypothesis. Journal of Clinical Investigation 74 (1984) 745-752
23. Paxton J.W. Drug binding to plasma proteins. New Zealand Medical Journal 98 (1985) 245-248
24. Piafsky K.M. Disease-induced changes in the plasma binding of basic drugs. Clinical Pharmacokinetics 5 (1980) 246-262
25. Rowland M., and Tozer T.N. Clinical pharmacokinetics- concepts and applications. 3rd ed. (1995), Williams & Wilkins
26. Schreiber G., Howlett G., Nagashima M., Millership A., Martin H., Urban J., et al. The acute phase response of plasma-protein synthesis during experimental inflammation. Journal of Biological Chemistry 257 (1982) 271-277
27. Spanner S., Hall R.C., and Ansell G.B. Arterio-venous differences of choline and choline lipids across the brain of rat and rabbit. Biochemical Journal 154 (1976) 133-140
28. Terao N., and Shen D.D. Alterations in serum protein binding and pharmacokinetics of l-propranolol in the rat elicited by the presence of an indwelling venous catheter. Journal of Pharmacology and Experimental Therapeutics 227 (1983) 369-375
29. Van Der Graaf P.H., Van Schaick E.A., Visser S.A., De Greef H.J., Ijzerman A.P., and Danhof M. Mechanism-based pharmacokinetic-pharmacodynamic modeling of antilipolytic effects of adenosine A(1) receptor agonists in rats: Prediction of tissue-dependent efficacy in vivo. Journal of Pharmacology and Experimental Therapeutics 290 (1999) 702-709
30. Wagner O.F., Nowotny P., Vierhapper H., and Waldhausl W. Plasma concentrations of endothelin in man: Arterio-venous differences and release during venous stasis. European Journal of Clinical Investigation 20 (1990) 502-505
31. Wright J.D., Boudinot F.D., and Ujhelyi M.R. Measurement and analysis of unbound drug concentrations. Clinical Pharmacokinetics 30 (1996) 445-462
32. Yasuhara M., Fujiwara J., Kitade S., Katayama H., Okumura K., and Hori R. Effect of altered plasma protein binding on pharmacokinetics and pharmacodynamics of propranolol in rats after surgery: Role of alpha-1-acid glycoprotein. Journal of Pharmacology and Experimental Therapeutics 235 (1985) 513-520